• Wion
  • /World
  • /China's Sinovac vaccine has general efficacy of 50.4% in Brazil trials

China's Sinovac vaccine has general efficacy of 50.4% in Brazil trials

A coronavirus vaccine developed by China’s Sinovac showed “general efficacy” of 50.38% in a late-stage trial in Brazil.